肝加欣联合血脂康治疗高脂血症脂肪肝62例  

Clinical effects of Ganjiaxinpian and Xuezhikang capsule on hyperlipidemia fatty liver

作　　者：蒋远明[1] 唐坤伦[1] 王容[1] 赵川[1] 谢巍[1] 钱春英[1] 

机构地区：[1]遂宁市中心医院,四川遂宁629000

出　　处：《西部医学》2009年第5期792-794,共3页Medical Journal of West China

摘　　要：目的观察肝加欣联合血脂康治疗高脂血症脂肪肝肝功能异常的临床疗效和安全性。方法将62例患者随机分成两组,对照组30例口服血脂康0.6 g,每日2次;治疗组32例加服肝加欣,每次4片,每日3次,疗程为3个月。治疗前、治疗后30 d、600 d、90 d检测血脂、肝功能和肝脏B超。结果治疗3个月后,治疗组血脂(TC、TG、LDL-C及HDL-C)、肝功能(ALT、AST)、B超脂肪肝图像及临床症状等项目与对照组比较有显著性差异(P<0.05)。降酶调脂总有效率治疗组为86.54%,对照组为10.00%(P<0.01)。B超图像好转率治疗组为80.77%,对照组为44.00%(P<0.01)。结论对高脂血症脂肪肝并肝功能异常患者,肝加欣片与血脂康联用疗效显著高于单用血脂康,且未见明显的毒副作用。Objective To observe the effects of Ganjiaxinpian and Xuezhikang Capsule for hyperlipidemia fatty liver （FLH）. Methods Patients were randomly divided into control group（30 case） and treatment group （32 case ）. The patients in treatment group were treated with Ganjiaxinpian and Xuezhikang Capsule, while The patients in control group with Xuezhikang Capsule. Results The effect of the treatment group was better than of the control group. Comclusion Ganjiaxinpian and Xuezhikang Capsule can decrease blood lipid,improve liver function,and has a better curative effect.

关 键 词：肝加欣 血脂康 高脂血症 脂肪肝 

分 类 号：R589.21[医药卫生—内分泌]